Bafna Pharmaceuticals Ltd.

NSE: BAFNAPH | BSE: 532989

Mid-range Performer

Download real time

80.40 3.48 (4.52%)

28.85% Fall from 52W High

19,165 NSE+BSE Volume

High volume today

NSE 25 Apr, 2025 3:31 PM (IST)

190.2

Market Cap

Below industry Median

0.0

Beta 1Year

Very Low volatility

Bafna Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bafna Pharmaceuticals Ltd. on BSE

Load latest

Bafna Pharmaceuticals Ltd.

10 Oct 2024

80.40

4.52%

Company Update

BAFNA PHARMACEUTICALS LTD. - 532989 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended September 30, 2024.

Bafna Pharmaceuticals Ltd.

28 Sep 2024

80.40

4.52%

SAST

BAFNA PHARMACEUTICALS LTD. - 532989 - Closure of Trading Window

BSE India

Intimation for Closure of Trading Window.

Bafna Pharmaceuticals Ltd.

26 Sep 2024

80.40

4.52%

AGM

BAFNA PHARMACEUTICALS LTD. - 532989 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

We herewith enclose the Voting Results of the 29th Annual General Meeting of the Company along with the Consolidated Scrutinizers Report.

Bafna Pharmaceuticals Ltd.

25 Sep 2024, 05:38PM

80.40

4.52%

Company Update

BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

We hereby inform that the Shareholders in the 29th Annual General Meeting held on September 25, 2024 inter-alia approved the re-appointment of Ms. Shanmugam Hemalatha (DIN: 02714329) as Whole-Time Director of the Company, for a period of 5 years.

Bafna Pharmaceuticals Ltd.

25 Sep 2024, 03:12PM

80.40

4.52%

AGM

BAFNA PHARMACEUTICALS LTD. - 532989 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Outcome / Proceedings of the 29th Annual General Meeting of the Company held on September 25, 2024

Bafna Pharmaceuticals Ltd.

09 Sep 2024

80.40

4.52%

Company Update

BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement Under Reg 30 Of SEBI (LODR) Regulations, 2015 - …

BSE India

We are glad to announce that the Company has been awarded All-Round Silver Star - Export Performance Award by Pharmaceuticals Export Promotion Council of India.

Bafna Pharmaceuticals Ltd.

03 Sep 2024

80.40

4.52%

Company Update

BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We herewith enclose the copy of Newspaper publication published in connection with 29th Annual General Meeting of the Company.

Bafna Pharmaceuticals Ltd.

02 Sep 2024

80.40

4.52%

AGM

BAFNA PHARMACEUTICALS LTD. - 532989 - Notice Of 29Th Annual General Meeting Of The Company For …

BSE India

We herewith enclose the Notice of 29th Annual General Meeting of the Company to be held for the F.Y 2023-2024

Bafna Pharmaceuticals Ltd.

02 Sep 2024

80.40

4.52%

Corp. Note

BAFNA PHARMACEUTICALS LTD. - 532989 - Reg. 34 (1) Annual Report.

BSE India

We herewith enclose the Annual Report of the Company for the F.Y 2023-2024.

Bafna Pharmaceuticals Ltd.

30 Aug 2024

80.40

4.52%

Corp. Action

BAFNA PHARMACEUTICALS LTD. - 532989 - Book Closure For 29Th Annual General Meeting (AGM)

BSE India

Intimation for Book Closure for the purpose of 29th Annual General Meeting of the Company.

Is Bafna Pharmaceuticals Ltd. worth buying?

23 Votes:

Buy 69.57%

Sell 21.74%

Hold 8.7%